481 related articles for article (PubMed ID: 14609838)
1. Globe conserving treatment of the only eye in bilateral retinoblastoma.
Lee V; Hungerford JL; Bunce C; Ahmed F; Kingston JE; Plowman PN
Br J Ophthalmol; 2003 Nov; 87(11):1374-80. PubMed ID: 14609838
[TBL] [Abstract][Full Text] [Related]
2. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
3. Vitreoretinal complications of retinoblastoma treatment.
Tawansy KA; Samuel MA; Shammas M; Murphree AL
Retina; 2006 Sep; 26(7 Suppl):S47-52. PubMed ID: 16946679
[TBL] [Abstract][Full Text] [Related]
4. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
[TBL] [Abstract][Full Text] [Related]
5. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
[TBL] [Abstract][Full Text] [Related]
6. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
[TBL] [Abstract][Full Text] [Related]
7. Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation.
Chan MP; Hungerford JL; Kingston JE; Plowman PN
Br J Ophthalmol; 2009 Jul; 93(7):891-4. PubMed ID: 19329423
[TBL] [Abstract][Full Text] [Related]
8. Treatment of retinoblastoma: The Institut Curie experience on a series of 730 patients (1995 to 2009).
Lumbroso-Le Rouic L; Savignoni A; Levy-Gabriel C; Aerts I; Cassoux N; Salviat F; Gauthier-Villars M; Freneaux P; Brisse H; Dendale R; Esteve M; Doz F; Desjardins L
J Fr Ophtalmol; 2015 Jun; 38(6):535-41. PubMed ID: 25976136
[TBL] [Abstract][Full Text] [Related]
9. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
[TBL] [Abstract][Full Text] [Related]
10. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
[TBL] [Abstract][Full Text] [Related]
11. Vitrectomy in eyes with unsuspected retinoblastoma.
Shields CL; Honavar S; Shields JA; Demirci H; Meadows AT
Ophthalmology; 2000 Dec; 107(12):2250-5. PubMed ID: 11097606
[TBL] [Abstract][Full Text] [Related]
12. [Results of combined chemotherapy and local ophtalmic therapy of children with intraocular retinoblastoma].
Balwierz W; Kobylarz J; Starzycka M; Dluzniewska A
Med Wieku Rozwoj; 2001; 5(3 Suppl 1):15-23. PubMed ID: 12004148
[TBL] [Abstract][Full Text] [Related]
13. Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors.
Shields CL; Mashayekhi A; Sun H; Uysal Y; Friere J; Komarnicky L; Shields JA
Ophthalmology; 2006 Nov; 113(11):2087-92. PubMed ID: 16949158
[TBL] [Abstract][Full Text] [Related]
14. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.
Shields CL; Shields JA; Needle M; de Potter P; Kheterpal S; Hamada A; Meadows AT
Ophthalmology; 1997 Dec; 104(12):2101-11. PubMed ID: 9400771
[TBL] [Abstract][Full Text] [Related]
15. Focal stereotactic external beam radiotherapy as a vision-sparing method for the treatment of peripapillary and perimacular retinoblastoma: preliminary results.
Sahgal A; Millar BA; Michaels H; Jaywant S; Chan HS; Heon E; Gallie B; Laperriere N
Clin Oncol (R Coll Radiol); 2006 Oct; 18(8):628-34. PubMed ID: 17051954
[TBL] [Abstract][Full Text] [Related]
16. Vitreous relapse following primary chemotherapy for retinoblastoma: is adjuvant diode laser a risk factor?
Gombos DS; Cauchi PA; Hungerford JL; Addison P; Coen PG; Kingston JE
Br J Ophthalmol; 2006 Sep; 90(9):1168-72. PubMed ID: 16707528
[TBL] [Abstract][Full Text] [Related]
17. Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma.
Wilson MW; Haik BG; Liu T; Merchant TE; Rodriguez-Galindo C
Am J Ophthalmol; 2005 Sep; 140(3):397-406. PubMed ID: 16138999
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
[TBL] [Abstract][Full Text] [Related]
19. Chemoreduction for unilateral retinoblastoma.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Naduvilath TJ
Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
[TBL] [Abstract][Full Text] [Related]
20. Retinoblastoma in Victoria, 1976-2000: changing management trends and outcomes.
Dondey JC; Staffieri S; McKenzie J; Davie G; Elder J
Clin Exp Ophthalmol; 2004 Aug; 32(4):354-9. PubMed ID: 15281966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]